Bence György, MD, PhD
Curriculum vitae
Date of birth: 07.01.1985
Nationality: Hungarian
Researcher unique identifier(s): ORCID ID: 0000-0003-0766-6246
Google Scholar: https://scholar.google.com/citations?user=Uk-LWCcAAAAJ&hl=en
LinkedIn: https://www.linkedin.com/in/bence-györgy-04534528/
from 07/2022
Eccellenza Assistant Professor​
from 02/2019
Group Leader, Institute of Molecular and Clinical Ophthalmology, Basel, Switzerland
Current position
Education
2009-2013
PhD, Molecular Genetics
Semmelweis University
Budapest, Hungary
During my PhD my research focused on extracellular vesicles, which are small membrane-bound particles, which contain materials from the secreting cells.
PhD advisor: Prof. Buzás Edit Irén
2011-2014
Postdoctoral fellowship
Harvard Medical School
Massachusetts General Hospital
During my post-doctoral years, I developed exosome-associated AAV vectors and gene editing-based therapeutics for various neurosensory diseases.
Advisors: Profs. David Corey, Xandra Breakefield and Casey Maguire
2003-2009
MD
Semmelweis University
Budapest, Hungary
I studied general medicine.
Summary of publications
Number of peer-reviewed publications: 42
Total number of impact factors: 236.79
Total number of citations: 8,424 (as of 19.05.2024)
h index: 27
Patents
-
Human cone photoreceptor optogenetic constructs, WO2024033837A1
-
Hybrid System for Efficient Gene Delivery to Cells of the Inner Ear, WO2017136764A1
-
Aav vectors encoding clarin-1 or gjb2 and uses thereof, WO2019200016A1
-
Methods and compositions for allele specific gene editing WO2020257514A1
Reviewing activities
-
Nature Neuroscience
-
Nature Biomedical Engineering
-
Nature Communications
-
Science Advances
-
American Journal of Human Genetics
-
Proceedings of the National Academy of Sciences of the United States of America
-
Molecular Therapy
-
Molecular Therapy Methods and Clinical Development
-
Molecular Therapy Nucleic Acids
-
CRISPR Journal
-
several other journals
Scientific Advisory Board
-
Swiss Expert Committee for Biosafety (SECB) - Gene Therapy Working Group
-
Usher Syndrome Society
-
Save Sight Now Europe
-
Fondation Pour l’Audition
Highlighted Awards
-
Eccellenza Professorhip, SNF
-
RetinAward, Swiss Vitreoretinal Group
-
Excellence in Research Award, American Society of Gene and Cell Therapy
-
Edward R. and Anne G. Lefler Center Postdoctoral Fellowship
-
American Society of Gene and Cell Therapy, Outstanding Poster Award
-
Excellent PhD Student Award, Semmelweis University, Association of Friends
-
Faculty 1000 recommendation on the article: György et al. 2010 Blood
-
Excellent Student at the Semmelweis University
-
Hungarian National Fellowship (awarded by the Hungarian Government to undergraduate students with outstanding academic achievements)
Funding
ONGOING:
-
2022-2027 Swiss National Science Foundation, Eccellenza, PCEFP3_202756, Precision Gene therapy for inherited blindness
-
2021-2024 ERA-NET + EJP: Genetic therapy for EYS- and USH2A-associated retinal dystrophy (PI)
-
2020-2024 Swiss National Science Foundation, NZX2080, Therapeutic RNA base editing for Stargardt disease, CHF 800K (PI)
-
RhyGaze AG - sponsored research agreement (PI)
​
PAST:
-
2020-2022 Foundation Fighting Blindness, Prime editing for Usher Syndrome Type 2A, (PI)
-
2020-2022 Developing a non-human primate model for Stargardt disease caused by the
ABCA4 G1961E mutation (co-PI) -
2020-2023 BEAM Therapeutics, Collaboration Agreement (co-PI)
Selected Invited Talks
2023
-
Biomedical Research Seminar, Bonn, Germany
-
Weilburg, DFG Research priority programme 2127
-
University of California Irvine, Distinguished Speaker Series, Irvine, CA, USA
2022
-
Vision 360 KKL, 2021 Triemli Hospital Summer Symposium, Zurich, Switzerland;
-
Telethon Institute of Genetics and Medicine, Online Seminar;
-
Usher Symposium Paris, France
-
Swiss Society of Toxicology, Basel, Switzerland
2019
-
Rudbeck Seminar, Uppsala University, Uppsala, Sweden;
-
Semmelweis Synposium, Budapest, Hungary
2018
-
Bertarelli Symposium, Boston, MA, USA
2017
-
Lefler Symposium, Boston, MA, USA
2016
-
Bertarelli Symposium, Boston, MA, USA;
-
Microvesicle and Exosome Seminar Series, Boston, MA, USA
Media
​
-
Kossuth Radio - Interview (in Hungarian) - link
-
Portfolio.hu - Interview (in Hungarian) - link
-
The London Economic - Radical cure for deafness may have been found thanks to lab animals
-
Scientific American - Gene Therapy Tackles a Common Birth Defect: Deafness
-
The New Yorker - High-tech hope for the hard of hearing
-
CNN, Unproven medical technique could save countless lives, billions of dollars